Lyra Therapeutics (LYRA) popped 16% in its IPO this past week, the latest biotech to surge in its public debut. It was joined by three SPACs, continuing an uptick in blank check activity.
Despite enduring the slowest spring since the financial crisis, the ...read more
SPACs are making big moves. This past week, sports betting platform DraftKings (DKNG) entered the public market through a SPAC merger, and Chamath Palihapitiya’s Social Capital Hedosophia II (IPOBU) and III (IPOCU) raised a combined $1 billion....read more
Updated on 4/27/2020.
One biotech and two SPACs are on the calendar for the week ahead. The IPO market is showing some early signs of opening up. Recent biotech IPOs have had strong debuts, SPAC activity has picked up, and a few deals in the pipeline like ...read more
The IPO market saw a jump in activity as one biotech and three SPACs went public this past week. The durability of the biotech industry was demonstrated once again, with ORIC Pharmaceuticals (ORIC) popping 61% on its first day. Four IPOs and one SPAC...read more
US IPO Weekly Recap: Biotech hot streak continues amid another wave of SPACs
Lyra Therapeutics (LYRA) popped 16% in its IPO this past week, the latest biotech to surge in its public debut. It was joined by three SPACs, continuing an uptick in blank check activity. Despite enduring the slowest spring since the financial crisis, the ...read more
How SPACs went mainstream
SPACs are making big moves. This past week, sports betting platform DraftKings (DKNG) entered the public market through a SPAC merger, and Chamath Palihapitiya’s Social Capital Hedosophia II (IPOBU) and III (IPOCU) raised a combined $1 billion....read more
US IPO Week Ahead: The IPO pipeline is active in a 1 IPO week
Updated on 4/27/2020. One biotech and two SPACs are on the calendar for the week ahead. The IPO market is showing some early signs of opening up. Recent biotech IPOs have had strong debuts, SPAC activity has picked up, and a few deals in the pipeline like ...read more
US IPO Weekly Recap: ORIC pops 61% and SPACs make a comeback
The IPO market saw a jump in activity as one biotech and three SPACs went public this past week. The durability of the biotech industry was demonstrated once again, with ORIC Pharmaceuticals (ORIC) popping 61% on its first day. Four IPOs and one SPAC...read more